Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02907086 · ClinicalTrials.gov registry record
Circulating Tumor Material in Colorectal Cancer and Melanoma
A clinical trial of Colorectal Cancer and Melanoma, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- 7
- Enrollment target
- 1
- Study location
NCT02907086: Completed study of Colorectal Cancer and Melanoma, sponsored by Abramson Cancer Center at Penn Medicine.
NCT02907086 is a study of Colorectal Cancer and Melanoma that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 7 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02907086, a study of Colorectal Cancer and Melanoma, has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- 7 participants
- Enrollment target
- 1
- Study location
Study Summary
Observational study to allow the collection of blood and medical information to evaluate the role of circulating tumor material in patients with colorectal cancer and melanoma
Conditions Studied
Interventions
- OTHER blood collection
Study Locations (1)
Pennsylvania
- Abramson Cancer Center of the University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2017-07-07 |
| Est. Completion | 2020-07-01 |
What the finished NCT02907086 record still lists
NCT02907086 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 7 participants, a relatively small participant target.
The record links to 1 condition, with Colorectal Cancer and Melanoma appearing as the primary indexed condition, and to 1 intervention - of which blood collection is the first listed.
NCT02907086 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02907086 about?
NCT02907086 is a clinical study titled "Circulating Tumor Material in Colorectal Cancer and Melanoma". Observational study to allow the collection of blood and medical information to evaluate the role of circulating tumor material in patients with colorectal cancer and melanoma
What is the current status of trial NCT02907086?
This trial is currently completed. The enrollment target is 7 participants. The study started on 2017-07-07. Estimated completion is 2020-07-01.
What conditions does trial NCT02907086 study?
This clinical trial studies the following conditions: Colorectal Cancer and Melanoma.
What interventions are being tested in trial NCT02907086?
The interventions under investigation include: blood collection (OTHER).
Who is sponsoring clinical trial NCT02907086?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02907086 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI